Zoltan Laboratories LLC
Records under this name other than the patents Zoltan Laboratories LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Back to Zoltan Laboratories LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,781,423 | Compounds to promote regeneration of bone marrow Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,790,685 | Combinations of Human Proteins to Enhance Viability of Transplanted Stem Cells and Progenitor Cells Term ended Term ended Nov 15, 2026 · High confidence | Term ended | Term ended Nov 15, 2026 | High confidence |
| US 8,778,674 | Combinations of Proteins to Enhance Viability of Stem Cells and Their Progenitors Before Transplantation Lapsed on the fee record Ended Jul 15, 2026 · High confidence | Lapsed on the fee record | Ended Jul 15, 2026 | High confidence |
| US 8,372,638 | Combinations of Proteins to Enhance Viability of Stem Cells and Their Progenitors Before Transplantation Lapsed on the fee record Ended Feb 12, 2025 · High confidence | Lapsed on the fee record | Ended Feb 12, 2025 | High confidence |
| US 7,048,914 | Placental alkaline phosphatase to control diabetes Term ended Term ended Apr 27, 2024 · From the USPTO record | Term ended | Term ended Apr 27, 2024 | From the USPTO record |
| US 7,014,852 | Alkaline phosphatase to induce weight loss or to reduce weight gain Term ended Term ended Jan 14, 2024 · From the USPTO record | Term ended | Term ended Jan 14, 2024 | From the USPTO record |
| US 7,943,606 | Compositions and methods to control abnormal cell growth Formerly held Lapsed on the fee record Ended May 17, 2023 · From the USPTO record | Lapsed on the fee record | Ended May 17, 2023 | From the USPTO record |
| US 7,858,085 | Alkaline phosphatase to control diabetes Term ended Ended no later than Dec 12, 2022 · From the USPTO record | Term ended | Ended no later than Dec 12, 2022 | From the USPTO record |
| US 8,603,464 | Alkaline phosphatase to reduce weight gain or induce weight loss Lapsed on the fee record Ended Dec 10, 2021 · From the USPTO record | Lapsed on the fee record | Ended Dec 10, 2021 | From the USPTO record |
| US 7,501,116 | Placental alkaline phosphatase to control diabetes Lapsed on the fee record Ended Mar 10, 2021 · From the USPTO record | Lapsed on the fee record | Ended Mar 10, 2021 | From the USPTO record |